Correa F M, Guilhaume S S, Saavedra J M
Section on Pharmacology, National Institute of Mental Health, Bethesda, MD 20892.
Brain Res. 1991 Apr 5;545(1-2):215-22. doi: 10.1016/0006-8993(91)91289-d.
Angiotensin-converting enzyme (ACE, kininase II, EC 3.4.15.1) was quantified in selected areas of the rat brain by 3 different methods. The enzyme activity was quantified by an enzymatic assay in homogenates of discrete brain areas with the use of the artificial substrate hippuryl-His-Leu-[14C]glycine. Binding of the specific ACE inhibitor [125I]351A was quantified after incubation of thin brain sections followed by quantitative autoradiography with comparison to [125I]standards. The antigenic sites of the enzyme were quantified by immunoautoradiography, using a polyclonal antibody to ACE in combination with [125I]protein A followed by quantitative autoradiography. There was a good correlation between the ACE activity, as determined by the quantitative enzymatic method, and both the enzyme inhibitor binding and the [125I]protein A binding, as determined by quantitative autoradiography, in brain areas and in anterior and posterior lobes of the pituitary gland. The present data demonstrate that ACE activity and ACE binding can be quantified in discrete tissue areas with different methods in a variety of conditions and with a high degree of accuracy.
采用3种不同方法对大鼠脑特定区域的血管紧张素转换酶(ACE,激肽酶II,EC 3.4.15.1)进行定量分析。使用人工底物马尿酰-His-Leu-[14C]甘氨酸,通过酶法测定离散脑区匀浆中的酶活性。将脑薄片孵育后,通过与[125I]标准品比较进行定量放射自显影,以定量特异性ACE抑制剂[125I]351A的结合情况。使用抗ACE多克隆抗体与[125I]蛋白A结合,随后进行定量放射自显影,以定量该酶的抗原位点。通过定量酶法测定的ACE活性与通过定量放射自显影测定的脑区及垂体前叶和后叶中的酶抑制剂结合及[125I]蛋白A结合之间存在良好相关性。目前的数据表明,在各种条件下,可通过不同方法在离散组织区域中高度准确地定量ACE活性和ACE结合情况。